To delineate clinical and histological features of the first Pneumocystis carinii infection affecting the immunocompetent host, P. carinii-specific histological stains were performed on autopsy lung specimens from 534 consecutive pediatric patients (those with AIDS and malignancies were excluded) in Santiago, Chile. P. carinii clusters were found in 4 (25%) of 16 infants who died of no apparent cause at arrival to the emergency department, and in 10 (2.9%) of 342 infants who died of multiple conditions at the hospital ( , Fisher's exact P = .002 test). This prompted us to analyze additional series of infants with sudden infant death syndrome (SIDS). In 161 additional SIDS cases, 47 (35.1%) of 134 infants from Chile and 4 (14.8%) of 27 infants from Oxford, United Kingdom, were found to have P. carinii clusters in the lungs. The quantity of P. carinii cysts was small compared with the numbers seen in immunocompromised hosts with P. carinii pneumonitis. This study provides histological evidence that primary P. carinii infection is associated with SIDS.
There is well-documented serological evidence that up to 94% of normal immunocompetent children have detectable antibody to Pneumocystis carinii by 30 months to 4 years of age [1, 2] , which indicates that primary P. carinii infection is one of the most common infections in humans and that exposure occurs early in life. Experimental evidence shows that the host response pattern associated with primary P. carinii infection in otherwise healthy animals is milder [3] [4] [5] than that associated with the usually massive infection seen in an immunocompromised host. Data for humans are scant: P. carinii in low numbers or mild focal pneumonitis has rarely been reported as an autopsy finding for presumably immunocompetent children, and then the infection has been judged to be latent, incidental organisms [6] . In contrast, there are abundant autopsy reports of interstitial plasma cell pneumonia in certain groups of debilitated, under-nourished, or premature infants, and reports of P. carinii pneumonia in infants and children with primary and secondary immunodeficiency syndromes [7, 8] .
Cross-sectional studies of children's lungs at autopsy might provide histological support for the assumption, based on serology, that primary P. carinii infection is a common occurrence in small children. Furthermore, a correlate with diagnosis before death might provide insight to the clinical presentation of primary infection in immunocompetent infants and children.
Because specific stains are needed to identify P. carinii in tissue samples, we undertook a prospective search for P. carinii by studying autopsy lung specimens from 534 consecutive children (those with AIDS and malignancies were excluded) that were obtained over a 6-year period at 2 major pediatric hospitals in Santiago, Chile. P. carinii was detected more frequently in infants who were dead on arrival at the emergency department and had an autopsy diagnosis compatible with sudden infant death syndrome (SIDS) than in children who died of multiple conditions at the hospital. These findings prompted us to expand our study to include an additional 134 infants in Chile who died at home and had a postautopsy diagnosis of SIDS, and 27 infants in Oxford, United Kingdom, who died of SIDS.
Methods
Lung specimens. A total of 695 autopsy lung samples were studied from infants and children in 4 different series. Formalin-fixed paraffin-imbedded lung specimens were provided by pathologists from each institution. Age, circumstances of death, and postautopsy diagnosis were recorded when available. SIDS was diagnosed if there was no recognized premortem disease, no significant microscopic or macroscopic pathological findings, and toxicology studies were negative.
Control subjects. All 342 infants who were aged between 5 days and 12 months at the time of death at the hospital were identified from the original 534 infants in series 1. These were selected as control subjects for the purpose of statistical comparison with the age-matched infants who died suddenly at home. Newborns aged !5 days were excluded.
Processing of lung specimens and stains. Lung tissue specimens were sectioned (5 mm) and stained with Grocott-Gomori methenamine-silver nitrate and hematoxylin-eosin stains. Slides from series 1 were examined by investigators blind to the diagnosis of SIDS, and slides from series 2 and 3 were examined by investigators aware of the diagnosis of SIDS. Slides in cases from Oxford were examined by investigators blind to the diagnosis of SIDS who also analyzed slides for possibly immunocompromised or immunocompromised patients with unknown P. carinii status. Specimens were examined by 2 different investigators (S.L.V. and J.C.W., C.P., or P.M.) in all cases. Discordant results were discussed, and cases were labeled as positive only if typical P. carinii cysts in clusters of 3 or more organisms were seen by both investigators. A third investigator reviewed positive cases (W.T.H. for Chilean samples, and S.G. for Oxford samples). Positive slides were subsequently stained with monoclonal antibody 3F6 (Dako Diagnostics, Carpinteria, CA), which recognizes an 82-kDa protein present in the cyst wall that is not altered by formalin or paraffin; all positive cases were confirmed by both methods (figure 1).
Clinicopathologic correlation. To gain insight into the clinical history and to better describe the histopathologic pattern of primary P. carinii infection in these children, the criteria described by Price and Hughes [9] for children with malignancies were retrospectively applied to P. carinii-positive patients with SIDS. Briefly, this scale of lung involvement with clinical correlation considers 2 asymptomatic stages and 1 symptomatic stage of P. carinii infection. Asymptomatic stages were described as isolated cysts with no parenchymal reaction of the lung (stage 1) or desquamation of organisms into the alveolar lumen with an increasing number of P. carinii and minimal or no inflammatory response in alveolar septa (stage 2). The symptomatic stage was defined as a host response consisting of alveolar desquamation and lymphocytic and plasma cell alveolar infiltrates (stage 3). Stage 3 was found by these investigators to correlate with clinical symptoms and radiographic signs of P. carinii pneumonitis in children with different types of cancer.
Statistical analysis. To compare the incidence of P. cariniipositive and -negative lung samples among infants who died at home of SIDS with the incidence among those who died at the hospital of multiple conditions, we used Fisher's exact test (using Epi-Info version 6; Centers for Disease Control and Prevention, Atlanta, GA). Control subjects were compared with infants with SIDS from series 1 and also with infants from series 2 and 3 combined.
was considered statistically significant. P ! .05
Results

Series 1.
Of 534 lung tissue specimens from consecutive pediatric patients that were blind to investigators with respect to age and diagnosis, 16 (3%) were found to be positive for P. carinii clusters. Primary autopsy diagnoses for these children were as follows: bronchopneumonia, 5 children; SIDS, 4; bronchitis, 1; generalized lipidosis, 1; and no diagnosis available, 1. The following underlying diseases suggestive of an immune defect were present in 4 patients who also had bronchopneumonia as a secondary diagnosis: severe combined immunodeficiency syndrome, congenital medullary aplasia, mucocutaneous candidiasis, and fulminant hepatitis. Age distribution and primary autopsy diagnoses for these patients are shown in table 1. P. carinii was detected in 4 (25%) of 16 infants who were dead at arrival to the emergency department and had a postautopsy diagnosis of SIDS compared with 10 (2.9%) of 342 infants who were aged between 5 days and 1 year and died of multiple conditions at the hospital ( , Fisher's exact P = .002 test). On the basis of this observation, we elected to examine a larger number of infants with a postautopsy diagnosis of SIDS.
Series 2-4 and control subjects. We examined an additional 134 infants with a primary autopsy diagnosis of SIDS who were autopsied at different hospitals in Santiago (series 2 and 3) and 27 infants who died of SIDS and were autopsied at a hospital in Oxford (series 4) (table 2). Ages of these infants ranged from 20 to 575 days (mean, 95 days; median, 60 days). Ages of control subjects ranged from 5 to 365 days (mean, 88 days; median, 60 days); control subjects were matched according to the age criterion for the diagnosis of SIDS.
Ten (2.9%) of 342 controls had P. carinii clusters compared with 47 (35.1%) of 134 Chilean infants with an autopsy diagnosis of SIDS in series 2 and 3 ( , Fisher's exact P = .0000001 test). Four (14.8%) of the 27 infants who died of SIDS in Oxford were found to have P. carinii clusters by histological analysis (table 2) .
Lung reaction, extent of P. carinii infection, and retrospective correlation with clinical manifestations before death. Of 55 P. carinii-positive patients with SIDS, 13 were not evaluable because the specimens had extensive postmortem autolysis. The clinicopathologic correlation criteria developed by Price and Hughes [9] were applied to 42 evaluable cases. Twelve and 25 Downloaded from https://academic.oup.com/cid/article-abstract/29/6/1489/306948 by guest on 11 March 2019 Figure 1 . A, Pneumocystis carinii clusters in lung tissue specimen from a 2-month-old infant diagnosed with sudden infant death syndrome (SIDS) (Grocott-Gomori methenamine-silver nitrate stain; original mag, ϫ330; bar, 10 mm). B, Smaller magnification (ϫ60) of A, illustrating that number of P. carinii clusters in patients with SIDS is few. C, Immunohistochemical analysis with monoclonal antibody 3F6 (Dako Diagnostics, Carpinteria, CA) of lung tissue specimen from a 4-month-old infant diagnosed with SIDS that reveals P. carinii cluster filling an alveolus (original mag, ϫ330; bar, 10 mm). Grocott-Gomori methenamine-silver nitrate stain is generally considered standard for detection of P. carinii in tissue specimens. It correlates well with immunohistochemical analysis with monoclonal antibody 3F6. P. carinii was detected by both techniques in all cases considered positive.
cases were categorized as stages 1 and 2, respectively (together, 88.1%), and 5 (11.9%) were categorized as stage 3, which suggests previous symptomatic disease.
Discussion
This study provides histological evidence of mild infection by P. carinii in presumably normal immunocompetent infants, a finding in agreement with serological evidence that most normal children are exposed to P. carinii at an early age [1, 2] . Mild, naturally occurring P. carinii infection has previously been observed in other mammals shortly after weaning: rabbits [3, 4] and piglets [5] . The young age of the patients and the characteristically mild histological pattern encountered suggest that our findings correspond to primary infection rather than to reactivated or secondary infection which has been histologically well described for the immunocompromised host [7] [8] [9] [10] [11] [12] .
This study also suggests an association between primary P. carinii infection and SIDS (table 2) . A small number of reports of cases of mild, focal P. carinii pneumonitis in infants with SIDS in Germany, the United States, and Chile in the 1950s [6, [10] [11] [12] provide further support of this association. In this study, P. carinii was also found in a relatively high proportion of patients with SIDS in Santiago and Oxford. Some innate flaws in the study must be considered. In series 2 and 3, slides were examined by investigators aware of the diagnosis of SIDS. To further assess the statistical significance found in series 1, the proportion of P. carinii-positive cases in series 2 and 3 was compared with that of P. carinii-positive control subjects (table  2) ; however, deaths in control subjects were not sudden, and (1) 39 (1) 534 (16) NOTE. Lung tissue sections were examined by Grocott-Gomori methenamine-silver nitrate staining, and positive specimens were also analyzed by immunohistochemical technique. NA, not available; SIDS, sudden infant death syndrome. cases were not matched with respect to underlying health status, prior drug therapies, and awareness of the diagnosis by investigators examining slides. The samples from Oxford (series 4) demonstrated that these findings were not a local phenomenon restricted to Chile; and so have much wider implications. Small numbers of P. carinii organisms found in infants with SIDS do not necessarily represent the onset of primary P. carinii infection; these organisms could correspond to a phase of P. carinii clearance that may take up to 1 year [13] . Therefore, a well-defined control group is needed in further studies to document the relevance of a potential pathogenic role of P. carinii in a proportion of SIDS cases.
A possible explanation for the pathogenic role of P. carinii in some infants with SIDS is that it reduces the level of pulmonary surfactant. This hypothesis is supported by evidence in both experimental models and studies of humans that showed that P. carinii infection leads to a decrease in the level of pulmonary surfactant [14] [15] [16] . Furthermore, a decreased surfactant level has been recently shown in an animal model to be directly related to P. carinii growth and occurs at early stages of P. carinii development [14] . Relevant to this study, infants with a postautopsy diagnosis of SIDS also have been consistently found to have decreased levels of surfactant [17] [18] [19] . In 1985, Talbert and Southhall [20] first hypothesized that a decrease in surfactant level may be a mechanism that triggers sudden death in infants when it occurs at a critical stage of their lung development. Our documentation of P. carinii in a relatively high proportion of SIDS cases suggests that P. carinii might play a role, alone or as an accompanying pathogen, in the decreased level of pulmonary surfactant that is documented in SIDS cases. Whether other pathogens that possess activity against phospholipase A 2 or other mechanisms could be implicated needs to be determined [18] .
Most (37 [88.1%] of 42) infants with SIDS who were positive for P. carinii and were evaluated by the clinicopathologic correlate developed by Price and Hughes [9] were categorized in stage 1 or 2, thus providing postmortem evidence that primary infection was asymptomatic in most SIDS cases. In agreement with this evaluation, the load of P. carinii organisms in SIDS cases was mild, and clusters were difficult to find histologically. Therefore, the terminal event of SIDS cannot be explained by these findings under the current understanding of P. carinii disease.
Alternatively, because P. carinii is largely a pathogen of the immunocompromised host, finding P. carinii more frequently in infants with SIDS might suggest that it marks the presence of an underlying immune defect in SIDS, just as P. carinii has served as a marker for HIV infection [21] [22] [23] [24] [25] .
Previous reports indicate that P. carinii can present as pneumonia in immunocompetent infants aged !3 months [26] and also suggest that P. carinii pneumonia might be associated with apnea [27, 28] . In our study, 5 (7.3%) of 68 immunocompetent infants aged from 5 days to 1 year in series 1 had bronchopneumonia as a primary autopsy diagnosis. This proportion, which agrees with findings in other studies [26, 27, 29, 30] , suggests that P. carinii infection should be included in the differential diagnosis of bronchopneumonia in presumably immunocompetent infants. Whether a clinically identifiable pattern is present in mild forms of primary infection occurring in infants who spontaneously recover is not known.
The data provide histological evidence of primary infection by P. carinii in apparently immunocompetent infants and children. They show that P. carinii infection is more common in infants aged !1 year who die in the community than in those who die in the hospital setting and that this infection can be asymptomatic. The high prevalence of P. carinii infection in infants with SIDS warrants further investigation.
